Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 76

Sort by

Sort Order Select

Journal Articles

Survival Patterns in Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma: Treatment Trajectories and Responses after the First Relapse

Ahmad S Halwani, MD, Hsu-Chih Chien, PhD MSc, Deborah Kay Morreall, BS, Vikas Patil, MS, Kelli M Rasmussen, MS, Catherine Li, PhD, Zachary R Burningham, PhD, Anthony S Masaquel, PhD MPH, Mary Halloran, PharmD, BCPS, Elisha Delong-Sieg, PharmD, Mathias Schulz, MD MBA, Jia Li, PhD, Brian C Sauer, PhD

Blood (2019) 134 (Supplement_1): 1622.

https://doi.org/10.1182/blood-2019-127719

Published: 2019

Journal Articles

Cancer- Associated Venous Thromboembolism (VTE) Characteristics in Blacks Compared to Whites in Durham County, North Carolina

Ibrahim Saber, MD, Maragatha Kuchibhatla, PhD, Alys Adamski, PhD MPH, Lisa C. Richardson, MDMPH, Nimia Reyes, MD MPH, Karon Abe, PhD, Michele G Beckman, MPH, Elizabeth Thames, Bhavana Singh, MD, Andrea Sitlinger, MD, Ryan Schulteis, Thomas L. Ortel, MD PhD

Blood (2019) 134 (Supplement_1): 3652.

https://doi.org/10.1182/blood-2019-132034

Published: 2019

Journal Articles

Superior Outcome in Elderly AML Patients Receiving Adjuvant Serotonin-Reuptake-Inhibitors during Induction

Rafee Talukder, MD, Martha P. Mims, MD PhD, Gustavo A. Rivero, MD

Blood (2019) 134 (Supplement_1): 1438.

https://doi.org/10.1182/blood-2019-131581

Published: 2019

Journal Articles

Outcomes in Multiple Myeloma Based on Comorbidities and Race

Martin W. Schoen, MDMPH, Kenneth R. Carson, MD PhD, Suhong Luo, MPH, Kristen M. Sanfilippo, MD MPHS

Blood (2019) 134 (Supplement_1): 383.

https://doi.org/10.1182/blood-2019-121807

Published: 2019

Journal Articles

Discontinuation Patterns in Patients Receiving Novel Oral Agents for Chronic Lymphocytic Leukemia in the Veterans Health Administration

Hsu-Chih Chien, PhD MSc, Vikas Patil, MS, Kelli M Rasmussen, MS, Christina Yong, MA, Juliana M L Biondo, MD, Mary Halloran, PharmD, BCPS, Sheila Shapouri, PharmD, MS, Mei Wu, PharmD, Zachary R Burningham, PhD, Brian C Sauer, PhD, Ahmad S Halwani, MD

Blood (2019) 134 (Supplement_1): 4309.

https://doi.org/10.1182/blood-2019-128645

Published: 2019

Journal Articles

Real-World Practice Patterns in a Nationwide Cohort of Veterans with Waldenström's Macroglobulinemia

Kelli M Rasmussen, MS, Vikas Patil, MS, Hsu-Chih Chien, PhD MSc, Deborah Kay Morreall, BS, Catherine Li, PhD, Zachary R Burningham, PhD, Brian C Sauer, PhD, Ahmad S Halwani, MD

Blood (2019) 134 (Supplement_1): 5270.

https://doi.org/10.1182/blood-2019-127738

Published: 2019

Journal Articles

Clinical Utility of B- and T-Cell Gene Rearrangement Studies in Blood and Bone Marrow Samples

Hadrian Mendoza, BS, Christopher Tormey, MD, Alexa J. Siddon, MD

Blood (2019) 134 (Supplement_1): 5223.

https://doi.org/10.1182/blood-2019-121747

Published: 2019

Journal Articles

Biomarkers of Hemostatic Activation and Inflammation Are Associated with Altered Coagulation Parameters in Sepsis Patients

Emily Bontekoe, Matthew T. Rondina, MD, Debra Hoppensteadt, PhD, Elizabeth Middleton, MD, Antoinette Blair, Fakiha Siddiqui, Divya Joshi, Alyssandra Abrenica, Iman Darwish, Maryanne Amour, Jawed Fareed, PhD

Blood (2019) 134 (Supplement_1): 2401.

https://doi.org/10.1182/blood-2019-130420

Published: 2019

Journal Articles

Outcomes of Black Patients with Multiple Myeloma in the Veterans Health Administration

Martin W. Schoen, MDMPH, Suhong Luo, MS, Kenneth R. Carson, MD PhD, Kristen M. Sanfilippo, MD

Blood (2018) 132 (Supplement 1): 840.

https://doi.org/10.1182/blood-2018-99-119845

Published: 2018

Journal Articles

Survival and Treatment of Black Patients with Chronic Lymphocytic Leukemia in the Veterans Health Affairs

Martin W. Schoen, MD MPH, Suhong Luo, MS, Kenneth R. Carson, MD PhD, Kristen M. Sanfilippo, MD

Blood (2018) 132 (Supplement 1): 4847.

https://doi.org/10.1182/blood-2018-99-114210

Published: 2018

Journal Articles

Monitoring the Effects of Direct Oral Anticoagulants with a Novel Point-of-Care Sensor: Results of a Pilot Clinical Study

Aman Opneja, MBBS, Debnath Maji, M.Tech, Pedram Mohseni, PhD, Michael A Suster, PhD, Evi X Stavrou, MD

Blood (2018) 132 (Supplement 1): 988.

https://doi.org/10.1182/blood-2018-99-118943

Published: 2018

Journal Articles

With Equal Access and Utilization of Resources,Younger African American Patients Have Superior Survival Compared to Caucasian Patients Diagnosed with Multiple Myeloma at the Veterans Affairs Hospitals

Nathanael Fillmore, PhD, Sarvari Venkata Yellapragada, MD, Mehmet Kemal Samur, PhD, Gustavo A. Rivero, MD, Saiju Pyarajan, PhD, Nhan Do, MD, Mary Brophy, MD MPH, Nikhil Munshi, MD

Blood (2018) 132 (Supplement 1): 3191.

https://doi.org/10.1182/blood-2018-99-119490

Published: 2018

Journal Articles

Risk of Herpes Zoster in Patients with Chronic Lymphocytic Leukemia Treated with Fludarabine or Bendamustine

Martin W. Schoen, MD MPH, Kristen M. Sanfilippo, MD MPHS, Theodore S. Thomas, MD MPHS, Suhong Luo, MS, Kahee A. Mohammed, MD MPH, Kenneth R. Carson, MD PhD

Blood (2017) 130 (Supplement 1): 2174.

https://doi.org/10.1182/blood.V130.Suppl_1.2174.2174

Published: 2017

Journal Articles

Treatment Evolution for Multiple Myeloma before Autologous Stem Cell Transplant and Its Relation with Engraftment Syndrome: 15 Years of Experience

Adolfo E Diaz, MD, Juan J. Toro, MD MSci, Shuko Lee, MS, Vivian Dee, NP, Francisca Cecilia Gushiken, MD

Blood (2017) 130 (Supplement 1): 3241.

https://doi.org/10.1182/blood.V130.Suppl_1.3241.3241

Published: 2017

Journal Articles

Risk of Myelodysplasia and Acute Myeloid Leukemia in Patients with Chronic Lymphocytic Leukemia Treated with Fludarabine and Bendamustine

Martin W. Schoen, MD MPH, Kristen M. Sanfilippo, MD MPHS, Theodore S. Thomas, MD MPHS, Suhong Luo, MS, Kenneth R. Carson, MD PhD

Blood (2017) 130 (Supplement 1): 5339.

https://doi.org/10.1182/blood.V130.Suppl_1.5339.5339

Published: 2017

Journal Articles

Incidence of Monoclonal Gammopathy of Undetermined Significance (MGUS) and Subsequent Transformation to Multiple Myeloma (MM) and Effect of Exposure to Agent Orange (AO) : A Single Center Experience from VA Detroit

Naresh Bumma, MD, Misako Nagasaka, MD, Seongho Kim, PhD, Hema M. Vankayala, MD, Shabbir Ahmed, MD, Pallavi Jasti, MD

Blood (2017) 130 (Supplement 1): 5383.

https://doi.org/10.1182/blood.V130.Suppl_1.5383.5383

Published: 2017

Journal Articles

Efficacy of CD101, a Novel Echinocandin, in Prevention of Pneumocystis Pneumonia (PCP): Thwarting the Biphasic Life Cycle of Pneumocystis

Melanie Cushion, Alan Ashbaugh, Keeley Lynch, Michael J. Linke, Ken Bartizal, PhD

Blood (2016) 128 (22): 3396.

https://doi.org/10.1182/blood.V128.22.3396.3396

Published: 2016

Journal Articles

Low Prevalence of CD30 Expression in Diffuse Large B-Cell Lymphoma Patients with MYC Expression

Dalia Mobarek, MD MSc, Hind Rafei, MD, Antoine Nafez Finianos, MD, Ehab El-Bahesh, MD, Fadi Alakeel, MD, Min-Ling Liu, MD PhD, Joao L. Ascensao, MD PhD

Blood (2016) 128 (22): 3561.

https://doi.org/10.1182/blood.V128.22.3561.3561

Published: 2016

Journal Articles

Surface CD5 Protein Risk Stratifies Chronic Lymphocytic Leukemia

Daphne R. Friedman, MD, Eross Guadeloupe, Alicia Volkheimer, J. Brice Weinberg, MD

Blood (2016) 128 (22): 3212.

https://doi.org/10.1182/blood.V128.22.3212.3212

Published: 2016

Journal Articles

Agent Orange Exposure Does Not Predict for Shorter Overall Survival in Patients with Chronic Lymphocytic Leukemia: A National Veteran Affairs Tumor Registry Study

Craig Mescher, MD, Nicole Randall, MD, Gobind Tarchand, Lisa M. Baumann Kreuziger, MD MS, Dave Gilbertson, Julie Tomaska, Vicki A. Morrison, MD

Blood (2016) 128 (22): 5568.

https://doi.org/10.1182/blood.V128.22.5568.5568

Published: 2016

NARROW

Survival Patterns in Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma: Treatment Trajectories and Responses after the First Relapse

Cancer- Associated Venous Thromboembolism (VTE) Characteristics in Blacks Compared to Whites in Durham County, North Carolina

Superior Outcome in Elderly AML Patients Receiving Adjuvant Serotonin-Reuptake-Inhibitors during Induction

Outcomes in Multiple Myeloma Based on Comorbidities and Race

Discontinuation Patterns in Patients Receiving Novel Oral Agents for Chronic Lymphocytic Leukemia in the Veterans Health Administration

Real-World Practice Patterns in a Nationwide Cohort of Veterans with Waldenström's Macroglobulinemia

Clinical Utility of B- and T-Cell Gene Rearrangement Studies in Blood and Bone Marrow Samples

Biomarkers of Hemostatic Activation and Inflammation Are Associated with Altered Coagulation Parameters in Sepsis Patients

Outcomes of Black Patients with Multiple Myeloma in the Veterans Health Administration

Survival and Treatment of Black Patients with Chronic Lymphocytic Leukemia in the Veterans Health Affairs

Monitoring the Effects of Direct Oral Anticoagulants with a Novel Point-of-Care Sensor: Results of a Pilot Clinical Study

With Equal Access and Utilization of Resources,Younger African American Patients Have Superior Survival Compared to Caucasian Patients Diagnosed with Multiple Myeloma at the Veterans Affairs Hospitals

Risk of Herpes Zoster in Patients with Chronic Lymphocytic Leukemia Treated with Fludarabine or Bendamustine

Treatment Evolution for Multiple Myeloma before Autologous Stem Cell Transplant and Its Relation with Engraftment Syndrome: 15 Years of Experience

Risk of Myelodysplasia and Acute Myeloid Leukemia in Patients with Chronic Lymphocytic Leukemia Treated with Fludarabine and Bendamustine

Incidence of Monoclonal Gammopathy of Undetermined Significance (MGUS) and Subsequent Transformation to Multiple Myeloma (MM) and Effect of Exposure to Agent Orange (AO) : A Single Center Experience from VA Detroit

Efficacy of CD101, a Novel Echinocandin, in Prevention of Pneumocystis Pneumonia (PCP): Thwarting the Biphasic Life Cycle of Pneumocystis

Low Prevalence of CD30 Expression in Diffuse Large B-Cell Lymphoma Patients with MYC Expression

Surface CD5 Protein Risk Stratifies Chronic Lymphocytic Leukemia

Agent Orange Exposure Does Not Predict for Shorter Overall Survival in Patients with Chronic Lymphocytic Leukemia: A National Veteran Affairs Tumor Registry Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only